Controlled Drug Delivery of Hydrophobic Drug: Development and Evaluation of Oral Controlled Drug Delivery of BCS Class-II Drug Glipizide

Jagtap, Rajesh, Jagtap, Sneha, Chavan, Sandeep

ISBN 10: 6202518065 / ISBN 13: 9786202518062

Published by LAP LAMBERT Academic Publishing, 2020

About this Item

NEW. SHIPS FROM MULTIPLE LOCATIONS.

Seller Inventory # ERICA82362025180656

Bibliographic Details

• Title: Controlled Drug Delivery of Hydrophobic Drug: Development and Evaluation of Oral Controlled Drug Delivery of BCS Class-II Drug Glipizide
• Publisher: LAP LAMBERT Academic Publishing
• Publication Date: 2020
• Language: English
• ISBN 10: 6202518065
• ISBN 13: 9786202518062
• Binding: paperback
• Condition: New
• Book Type: book

About this title

Synopsis

Glipizide, an oral hypoglycemic agent, is one of the most commonly prescribed drugs for the treatment of patients with type II diabetes mellitus. It is practically water-insoluble, thus it belongs to class-II of Biopharmaceutical Classification System (BCS). Glipizide has a relatively short elimination half-life (2–4 h), thereby requiring twice daily dosing in large number of patients, which often leads to non-compliance. Thus, there is a strong clinical need and market potential for a dosage form that will deliver glipizide in a controlled manner to a patient needing this therapy, thereby resulting in a better patient compliance. The aim of present investigation was to enhance the solubility by using β-cyclodextrin binary complexation and impart a controlled release in a single formulation in order to reduce dosing frequency.